196 related articles for article (PubMed ID: 12663327)
1. Effectiveness of inhaled corticosteroids in chronic obstructive pulmonary disease: immortal time bias in observational studies.
Suissa S
Am J Respir Crit Care Med; 2003 Jul; 168(1):49-53. PubMed ID: 12663327
[TBL] [Abstract][Full Text] [Related]
2. Immortal time bias in observational studies of drug effects.
Suissa S
Pharmacoepidemiol Drug Saf; 2007 Mar; 16(3):241-9. PubMed ID: 17252614
[TBL] [Abstract][Full Text] [Related]
3. Immeasurable time bias in observational studies of drug effects on mortality.
Suissa S
Am J Epidemiol; 2008 Aug; 168(3):329-35. PubMed ID: 18515793
[TBL] [Abstract][Full Text] [Related]
4. Inhaled corticosteroids in chronic obstructive pulmonary disease: results from two observational designs free of immortal time bias.
Kiri VA; Pride NB; Soriano JB; Vestbo J
Am J Respir Crit Care Med; 2005 Aug; 172(4):460-4. PubMed ID: 15901610
[TBL] [Abstract][Full Text] [Related]
5. Inhaled corticosteroids in chronic obstructive pulmonary disease and risk of death and hospitalization: time-dependent analysis.
Fan VS; Bryson CL; Curtis JR; Fihn SD; Bridevaux PO; McDonell MB; Au DH
Am J Respir Crit Care Med; 2003 Dec; 168(12):1488-94. PubMed ID: 14525798
[TBL] [Abstract][Full Text] [Related]
6. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease.
Lee TA; Wilke C; Joo M; Stroupe KT; Krishnan JA; Schumock GT; Pickard AS
Arch Intern Med; 2009 Aug; 169(15):1403-10. PubMed ID: 19667304
[TBL] [Abstract][Full Text] [Related]
7. [Do inhaled corticosteroids reduce mortality in chronic obstructive pulmonary disease?].
Bridevaux PO; Leuenberger P
Rev Med Suisse; 2005 Nov; 1(41):2673-4, 2677-9. PubMed ID: 16355882
[TBL] [Abstract][Full Text] [Related]
8. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
Sobieraj DM; White CM; Coleman CI
Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
[TBL] [Abstract][Full Text] [Related]
9. Survival of COPD patients using inhaled corticosteroids and long-acting beta agonists.
Mapel DW; Hurley JS; Roblin D; Roberts M; Davis KJ; Schreiner R; Frost FJ
Respir Med; 2006 Apr; 100(4):595-609. PubMed ID: 16199151
[TBL] [Abstract][Full Text] [Related]
10. Economic evaluation of treating chronic obstructive pulmonary disease with inhaled corticosteroids and long-acting beta2-agonists in a health maintenance organization.
Gagnon YM; Levy AR; Spencer MD; Hurley JS; Frost FJ; Mapel DW; Briggs AH
Respir Med; 2005 Dec; 99(12):1534-45. PubMed ID: 16291076
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
Baker WL; Baker EL; Coleman CI
Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
[TBL] [Abstract][Full Text] [Related]
12. Inhaled corticosteroids and the risk of mortality and readmission in elderly patients with chronic obstructive pulmonary disease.
Sin DD; Tu JV
Am J Respir Crit Care Med; 2001 Aug; 164(4):580-4. PubMed ID: 11520719
[TBL] [Abstract][Full Text] [Related]
13. Economic assessment of early initiation of inhaled corticosteroids in chronic obstructive pulmonary disease using propensity score matching.
Akazawa M; Biddle AK; Stearns SC
Clin Ther; 2008; 30 Spec No():1003-16. PubMed ID: 18640475
[TBL] [Abstract][Full Text] [Related]
14. Survival with tiotropium compared to long-acting Beta-2-agonists in Chronic Obstructive Pulmonary Disease.
Gershon AS; Wang L; To T; Luo J; Upshur RE
COPD; 2008 Aug; 5(4):229-34. PubMed ID: 18671148
[TBL] [Abstract][Full Text] [Related]
15. Impact of regular inhaled corticosteroid use on chronic obstructive pulmonary disease outcomes.
Vollmer WM; Peters D; Crane B; Kelleher C; Buist AS
COPD; 2007 Jun; 4(2):135-42. PubMed ID: 17530507
[TBL] [Abstract][Full Text] [Related]
16. Bias in observational study of the effectiveness of nasal corticosteroids in asthma.
Suissa S; Ernst P
J Allergy Clin Immunol; 2005 Apr; 115(4):714-9. PubMed ID: 15805989
[TBL] [Abstract][Full Text] [Related]
17. Inhaled corticosteroids are more effective in COPD patients when used with LABA than with SABA.
Kiri VA; Bettoncelli G; Testi R; Viegi G
Respir Med; 2005 Sep; 99(9):1115-24. PubMed ID: 15921904
[TBL] [Abstract][Full Text] [Related]
18. Mortality risk in patients receiving drug regimens with theophylline for chronic obstructive pulmonary disease.
Lee TA; Schumock GT; Bartle B; Pickard AS
Pharmacotherapy; 2009 Sep; 29(9):1039-53. PubMed ID: 19698009
[TBL] [Abstract][Full Text] [Related]
19. Enhanced persistence with tiotropium compared with other respiratory drugs in COPD.
Breekveldt-Postma NS; Koerselman J; Erkens JA; Lammers JW; Herings RM
Respir Med; 2007 Jul; 101(7):1398-405. PubMed ID: 17368011
[TBL] [Abstract][Full Text] [Related]
20. Comparison of hospitalizations, emergency department visits, and costs in a historical cohort of Texas Medicaid patients with chronic obstructive pulmonary disease, by initial medication regimen.
Rascati KL; Akazawa M; Johnsrud M; Stanford RH; Blanchette CM
Clin Ther; 2007 Jun; 29(6):1203-13. PubMed ID: 17692734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
